Commercialisation of Patient-derived breast cancer organoids for drug discovery
Lead Participant:
CELLESCE LIMITED
Abstract
no public description
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| CELLESCE LIMITED | £85,412 | £ 85,412 |
Participant |
||
| DENTHERAPY LIMITED | ||
| INNOVATE UK |
People |
ORCID iD |
| Paul Jenkins (Project Manager) |